FISH(Fluorescence,Situ Hybridization) 프로브 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Fluorescence In Situ Hybridization Probe Market size is expected to reach USD 3.40 Billion in 2034 from USD 1.72 Billion (2025) growing at a CAGR of 7.89% during 2026-2034.

The Global Fluorescence In Situ Hybridization (FISH) Probe Market is expanding as molecular diagnostic technologies become increasingly important in medical and genetic research. FISH probes are used to detect and localize specific DNA or RNA sequences within cells, enabling precise identification of genetic abnormalities. This technique is widely used in cancer diagnostics, prenatal testing, and cytogenetic research.

One of the major drivers of the market is the growing demand for accurate genetic testing and personalized medicine. Healthcare professionals rely on FISH technology to detect chromosomal abnormalities and identify disease-related genetic markers. Additionally, advancements in fluorescence imaging and probe design have improved the sensitivity and reliability of FISH-based diagnostic tests.

Looking ahead, the FISH probe market is expected to benefit from continued developments in molecular diagnostics and genomic research. The integration of automated imaging systems and advanced laboratory technologies may further enhance testing efficiency. As genetic testing becomes more widely adopted in clinical practice, the demand for fluorescence in situ hybridization probes is projected to increase globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• DNA Probe
• RNA Probe
• Others

By Application

• Cancer Diagnosis
• Genetic Disorders
• Infectious Disease Diagnosis
• Others

By End User

• Hospitals and Diagnostic Laboratories
• Research and Academic Institutes
• Pharmaceutical and Biotechnology Companies

COMPANIES PROFILED

• Abnova Corp, LGC Biosearch Technologies, Oxford Gene Technology IP Ltd, Horizon Diagnostics, Agilent Technologies Inc, Perkinelmer Inc, Genemed Biotechnologies Inc, Biocare Medical LLC, Qiagen Exiqon AS, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. DNA Probe Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. RNA Probe Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Cancer Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Genetic Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Infectious Disease Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals and Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Research and Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abnova Corp
  • 9.2.2 LGC Biosearch Technologies
  • 9.2.3 Oxford Gene Technology IP Ltd
  • 9.2.4 Horizon Diagnostics
  • 9.2.5 Agilent Technologies Inc
  • 9.2.6 Perkinelmer Inc
  • 9.2.7 Genemed Biotechnologies Inc
  • 9.2.8 Biocare Medical LLC
  • 9.2.9 Qiagen (Exiqon A/S)
  • 9.2.10 Thermo Fisher Scientific Inc